ImmunoCure Inc Rebrands as Pozescaf - Launches New Era in Drug Discovery

ImmunoCure Inc., a pioneering biotech company in AI based drug discovery and development, officially announced its rebranding to Pozescaf during a landmark event held at its R&D facility located at the Genome Valley, Shamirpet,Medchal-Malkajgiri Dist, Hyderabad, Telangana-500078.

The rebranding marks a significant milestone in the company’s mission to accelerate innovative therapies and expand its global footprint in precision medicine. The new identity, Pozescaf, reflects the company’s evolving vision and its commitment to advanced research in drug discovery.

The event featured the launch of the new corporate website by Dr. Srinivas Guntha, Managing Director of AAP Pharma Technologies India Pvt. Ltd., symbolizing the company’s transition to a more globally integrated brand.

Key company leaders and stakeholders attended the ceremony, including Cofounders Dr. Ravikumar Muttineni, Dr.Kranthi Raj Kodamala, Dr. Murali Ginjupalli and CEO Mr. Nagesh Bethamcherla. Also present were senior members of the scientific and technical leadership: Dr. Ramesh Reddigunta, Dr. Amit Kumar Shrivastava and Mr. BhanukishoreKallepalli.

In a special announcement during the event, Dr.Kranthi Raj Kodamala was formally welcomed as the new Chief Scientist Officer (CSO). Dr. Ravikumar Muttineni extended a warm welcome to Dr.Kodamala, while Dr. Murali Ginjupalli introduced the entire leadership team to mark the occasion.

“This rebranding is more than a name change.. it represents our strategic growth, our commitment to innovative science and our readiness to deliver solutions that make a global impact,” said CEO Mr. Nagesh Bethamcherla.

The company’s new brand identity and website are now live at www.Pozescaf.com, offering insights into its expanded services, research pipelines and global partnerships.

About Pozescaf

Pozescaf (formerly ImmunoCure Inc.) is a biotechnology company dedicated to drug discovery and innovative research solutions. Based in Genome Valley, Hyderabad, Pozescaf collaborates with global partners to develop next-generation therapies targeting critical unmet medical needs.